Infographic | August 30, 2021

What Is An IND And Why Do I Need One?

Investigational New Drug (IND) Programs

Drug developers looking to bring their therapies into human clinical testing in the United States are required to
file an Investigational New Drug Application (IND) with the United States Food & Drug Administration (FDA). Let us
explore the purpose of the IND, their types, the format, what the FDA really cares about, and how the applications are
approved by the FDA.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader